page contents

Trump administration courts investors in broad effort to combat rising health care costs

The Trump administration is battling rising health costs by going after the incentives that help drive higher prices.

That’s the idea at the heart of the new payment model for high-priced drugs laid out by the administration last week. It is also the driving force behind a new initiative to engage health care investors about how reimbursement policies are fueling fu…
Health and Science

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close